Atlas Trials

Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

Clinical trial NCT02613182 · TERMINATED

Trial details

NCT number
NCT02613182
Sponsor
Prothena Biosciences Ltd.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
AL Amyloidosis
Start date
2016-02-01
Primary completion
2018-05-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.